Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell L Shiffman

Showing results (21-30 of 209) with videos related to

Pageof 21
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2009
What future for ribavirin?Mitchell L Shiffman
Oncology|July 10, 2010
Impact of peginterferon maintenance therapy on the risk of developing hepatocellular carcinoma in patients with chronic hepatitis C virusMitchell L Shiffman
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2016
Universal screening for chronic hepatitis C virusMitchell L Shiffman
Clinics in Liver Disease|July 16, 2008
Optimizing the current therapy for chronic hepatitis C virus: peginterferon and ribavirin dosing and the utility of growth factorsMitchell L Shiffman
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 26, 2008
Impact of the donor liver with steatosis in patients with hepatitis C virus: not so FAstNevin Yilmaz, Mitchell L Shiffman
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
HCV F1/F2 patients: treat now or continue to waitMitchell L Shiffman, Yves Benhamou
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
Patients with HCV and F1 and F2 fibrosis stage: treat now or wait?Mitchell L Shiffman, Yves Benhamou
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2014
Cure of HCV related liver diseaseMitchell L Shiffman, Yves Benhamou
Clinics in Liver Disease|July 19, 2005
Approach to the management of patients with chronic hepatitis C who failed to achieve sustained virologic responseAmrita Sethi, Mitchell L Shiffman
Liver International : Official Journal of the International Association for the Study of the Liver|January 4, 2012
Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?Mitchell L Shiffman, Rafael Esteban
Pageof 21

Showing results (21-30 of 209) with videos related to

Sort By:
Pageof 21
Liver International : Official Journal of the International Association for the Study of the Liver|February 12, 2009
What future for ribavirin?Mitchell L Shiffman
Oncology|July 10, 2010
Impact of peginterferon maintenance therapy on the risk of developing hepatocellular carcinoma in patients with chronic hepatitis C virusMitchell L Shiffman
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2016
Universal screening for chronic hepatitis C virusMitchell L Shiffman
Clinics in Liver Disease|July 16, 2008
Optimizing the current therapy for chronic hepatitis C virus: peginterferon and ribavirin dosing and the utility of growth factorsMitchell L Shiffman
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 26, 2008
Impact of the donor liver with steatosis in patients with hepatitis C virus: not so FAstNevin Yilmaz, Mitchell L Shiffman
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
HCV F1/F2 patients: treat now or continue to waitMitchell L Shiffman, Yves Benhamou
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
Patients with HCV and F1 and F2 fibrosis stage: treat now or wait?Mitchell L Shiffman, Yves Benhamou
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2014
Cure of HCV related liver diseaseMitchell L Shiffman, Yves Benhamou
Clinics in Liver Disease|July 19, 2005
Approach to the management of patients with chronic hepatitis C who failed to achieve sustained virologic responseAmrita Sethi, Mitchell L Shiffman
Liver International : Official Journal of the International Association for the Study of the Liver|January 4, 2012
Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?Mitchell L Shiffman, Rafael Esteban
Pageof 21